Atlas Trials

Acute Myeloid Leukemia (AML) Relapse

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Acute Myeloid Leukemia (AML) Relapse

RecordFirmDate
A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation. (NCT06641648)Peking University First Hospital2025-11-01
Association of Ex Vivo Drug Response ( EVDR) and Clinical Outcome in Acute Myeloid Leukaemia (EXCYTE-2) (NCT06648512)Exscientia AI Limited2024-05-13
Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (NCT03207191)Philogen S.p.A.2016-12-02

Track Acute Myeloid Leukemia (AML) Relapse automatically

Every clearance here is in the API, with alerts when new ones post.